Woodline Partners’s Sangamo Therapeutics SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$15.6K Buy
28,859
+9,619
+50% +$5.21K ﹤0.01% 910
2025
Q1
$12.6K Buy
+19,240
New +$12.6K ﹤0.01% 891